Relapsed Classical Hodgkin Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed Classical Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma (NCT04788043) | Ranjana Advani | 2022-06-21 |
Track Relapsed Classical Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.